+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Retinopathy Drug"

Proliferative Diabetic Retinopathy Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Proliferative Diabetic Retinopathy Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 117 Pages
  • Global
From
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 286 Pages
  • Global
From
Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 32 Pages
  • Global
From
Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 69 Pages
  • Global
From
Non-Proliferative Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Non-Proliferative Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 40 Pages
  • Global
From
2023 Global Forecast for Proliferative Diabetic Retinopathy Therapeutics Market (2024-2029 Outlook) - High Tech & Emerging Markets Report - Product Thumbnail Image

2023 Global Forecast for Proliferative Diabetic Retinopathy Therapeutics Market (2024-2029 Outlook) - High Tech & Emerging Markets Report

  • Report
  • July 2023
  • 132 Pages
  • Global
From
Loading Indicator

The Retinopathy Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat diseases of the eye. Retinopathy drugs are used to treat diseases of the retina, such as age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. These drugs can be administered orally, topically, or by injection. Commonly used retinopathy drugs include anti-VEGF agents, corticosteroids, and photodynamic therapy. The Retinopathy Drug market is highly competitive, with many companies developing and marketing drugs to treat retinopathy. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, Roche, and Bayer. Show Less Read more